AGRX - Agile Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts6666
Avg. Estimate-0.08-0.08-0.35-0.27
Low Estimate-0.09-0.11-0.38-0.77
High Estimate-0.07-0.05-0.320.11
Year Ago EPS-0.11-0.11-0.58-0.35
Revenue EstimateCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
No. of Analysts6666
Avg. EstimateN/AN/AN/A21.46M
Low EstimateN/AN/AN/A5.02M
High EstimateN/AN/AN/A38.4M
Year Ago SalesN/AN/AN/AN/A
Sales Growth (year/est)N/AN/AN/AN/A
Earnings History9/29/201812/30/20183/30/20196/29/2019
EPS Est.-0.15-0.15-0.1-0.11
EPS Actual-0.11-0.11-0.13-0.08
Difference0.040.04-0.030.03
Surprise %26.70%26.70%-30.00%27.30%
EPS TrendCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.08-0.08-0.35-0.27
7 Days Ago-0.08-0.08-0.35-0.27
30 Days Ago-0.08-0.08-0.35-0.27
60 Days Ago-0.08-0.08-0.35-0.27
90 Days Ago-0.11-0.1-0.44-0.33
EPS RevisionsCurrent Qtr. (Sep 2019)Next Qtr. (Dec 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesAGRXIndustrySectorS&P 500
Current Qtr.27.30%N/AN/A-0.02
Next Qtr.27.30%N/AN/A0.07
Current Year39.70%N/AN/A-0.02
Next Year22.90%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.07
Past 5 Years (per annum)N/AN/AN/AN/A